Volume 23 - Issue 11 - November 2015
11/19/2015
Lisa B. Samalonis
Many new therapies are in development.
Many new therapies are in development.
Many new therapies are in...
11/19/2015
The Dermatologist
Research in Review
11/17/2015
A review of recent news, research and treatment related to rosacea.
A review of recent news, research and treatment related to rosacea.
A review of recent news,...
11/17/2015
The Dermatologist
11/17/2015
In this excerpt from the recently published book, Practical Psoriasis Management, the authors discuss the use of cyclosporine for acute treatment of severe psoriasis and when other systemic medications have failed.
In this excerpt from the recently published book, Practical Psoriasis Management, the authors discuss the use of cyclosporine for acute treatment of severe psoriasis and when other systemic medications have failed.
In this excerpt from the...
11/17/2015
The Dermatologist
Industry News
11/17/2015
Finacea Foam, 15% is a recently FDA-approved topical treatment for patients experiencing the inflammatory papules and pustules of mild to moderate rosacea.
Finacea Foam, 15% is a recently FDA-approved topical treatment for patients experiencing the inflammatory papules and pustules of mild to moderate rosacea.
Finacea Foam, 15% is a recently...
11/17/2015
The Dermatologist
Research in Review
11/17/2015
Brett Kopelan
As treatment progresses for epidermolysis bullosa, a need for dermatologists who treat adults with the disorder exists.
As treatment progresses for epidermolysis bullosa, a need for dermatologists who treat adults with the disorder exists.
As treatment progresses for...
11/17/2015
The Dermatologist
Board Review
11/17/2015
Bruce Theirs, MD, FAAD
1. Difficulty walking and these conjunctival lesions developed during childhood. Which statement is true?
1. Difficulty walking and these conjunctival lesions developed during childhood. Which statement is true?
1. Difficulty walking and...
11/17/2015
The Dermatologist
Spotlight
11/17/2015
Benjamin Barankin, MD, FRCPC
Dr. Day is a dermatologist who specializes in laser, cosmetic and medical dermatology in New York City.
Dr. Day is a dermatologist who specializes in laser, cosmetic and medical dermatology in New York City.
Dr. Day is a dermatologist...
11/17/2015
The Dermatologist
News
11/17/2015
Lisa B. Samalonis
The Fall conference brought together dermatologists to interact, learn and network.
The Fall conference brought together dermatologists to interact, learn and network.
The Fall conference brought...
11/17/2015
The Dermatologist
News
11/17/2015
The FDA approved the Biologics License Application for Imlygic (talimogene laherparepvec, Amgen), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in...
The FDA approved the Biologics License Application for Imlygic (talimogene laherparepvec, Amgen), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in...
The FDA approved the Biologics...
11/17/2015
The Dermatologist
Case Report and Brief Review
12/18/2015
Miguel Villacorta, BS; Rogerio Faillace, MD; Elyse Julian, BS; Fawn Winkelman, DO
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
A 5-year-old girl presented with a 3-week history of multiple discrete, pink, scaly plaques. The plaques were ovoid, ranged from 0.5 to 3 cm in diameter, and were slightly raised, blanchable, and pruritic.
A 5-year-old girl presented with...
12/18/2015
The Dermatologist
